ISBioTech Fall Meeting: Featured Presentation by Dr. Jeffrey A. Shaman, GENEWIZ, Inc.
(firmenpresse) - SOUTH PLAINFIELD, NJ -- (Marketwired) -- 10/10/13 -- , leading global genomic service provider, will join the ISBioTech First Fall Meeting next week in Rosslyn, Virginia, with a featured presentation by Dr. Jeffrey A. Shaman, Business Development Lead, Translational Genomics.
Speaking about detection and identification of cell and virus bank contamination, Dr. Shaman will discuss relevant concerns and challenges presented by biopharmaceutical banks. He will further review study data suggesting that next generation sequencing technologies provide broad range, sensitive, and long-lasting information for application within larger safety monitoring programs, during the featured presentation, 'What's in My Bank? Approaches to Adventitious Virus, Microbial, and Cell Line Testing.'
As a full-service next generation sequencing provider, GENEWIZ offers services for research and discovery of microbes and viruses, as well as for biologics testing in a GLP-compliant regulatory environment. GENEWIZ also provides for the detection and identification of virus, microbial, and host and feeder cell contaminants in cell lines. In conjunction with other methods, NGS-based contamination testing provides a highly sensitive solution to established biosafety programs, such validation of biopharmaceuticals and biosimilars, and characterization of virus banks, virus vaccines, and cell banks.
Highlighting two programs, Cell Line Development & Banking, and Rapid Scale-Up & Testing, the is designed to share the techniques and best practices needed to establish stable and well-characterized cell banks, as well as the processes and testing methods for rapid scale-up of clinical trial materials and licensed products.
is a global contract research organization (CRO) specializing in genomic services, including DNA sequencing, gene synthesis, molecular biology, genomic, bioinformatics, and GxP/CLIA regulatory-compliant services. GENEWIZ leads the industry in outsourcing partnerships with pharmaceutical, biotechnology, clinical, academic, and government institutions.
Headquartered in South Plainfield, NJ, GENEWIZ, Inc. is a privately-held global enterprise with locations in Boston, MA; Washington, DC Metro; Research Triangle Park, NC; San Diego, CA; San Francisco, CA; and Seattle, WA. International locations include Beijing, China; Suzhou, China; London, United Kingdom; and Tokyo, Japan.
GENEWIZ, Inc.
Global Headquarters
115 Corporate Boulevard
South Plainfield, NJ 07080
+1-908-222-0711
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 10.10.2013 - 10:00 Uhr
Sprache: Deutsch
News-ID 304591
Anzahl Zeichen: 0
contact information:
Town:
SOUTH PLAINFIELD, NJ
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 210 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ISBioTech Fall Meeting: Featured Presentation by Dr. Jeffrey A. Shaman, GENEWIZ, Inc."
steht unter der journalistisch-redaktionellen Verantwortung von
GENEWIZ, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
